ESMO Preceptorship on Colorectal Cancer 2022: Mexico City
![ESMO-Preceptorship-Colorectal-Cancer-2022-1000x250-march](/var/esmo/storage/images/media/esmo/meetings/2022/_preceptorships-2022/esmo-preceptorship-colorectal-cancer-2022-1000x250-march/9798763-1-eng-GB/esmo-preceptorship-colorectal-cancer-2022-1000x250-march.jpg)
- Start date
- 24 Mar 2022
- End date
- 25 Mar 2022
- Location
- Mexico City, Mexico
Learning objectives
- To learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings
- To understand the importance of pathology and histoprognostic factors
- To learn about the management of patients after progression, side-effects of treatments and in special situations
Accreditation
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Dirk Arnold, Germany
- Rachel Riechelmann, Brazil
- Erika Ruíz-Garcia, Mexico